TYP-1-INTERFERON-DIAGNOSEMITTEL

Patent europeic · EP2473636 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2473636
Numer da la dumonda
EP10814513
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
02-09-2010
Publitgà
11-07-2012
Concedì
26-10-2016
La protecziun finescha il pli tard
01-09-2030
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
C12Q 1/68 (2006.01)
Prioritad
US 239630 P 03.09.2009
Dumonda PCT
PCT/US2010/047721 02.09.2010
Publicaziun PCT
WO2011/028933 10.03.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  4. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  5. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  6. 26-10-2016

    Concedì

    Published in Swissreg on 26.10.2016

Partidas

Possessur

MedImmune, LLC

One MedImmune Way, Gaithersburg, MD 20878, US

Inventur

HIGGS, Brandon

Gaithersburg, MD 20878, US

ZHU, Wei

Boyds, MD 20841, US

MOREHOUSE, Chris

Middletown, MD 21769, US

WHITE, Barbara

Finksburg, MD 21048, US

JALLAL, Bahija

Potomac, MD 20854, US

YAO, Yihong

Boyds, MD 20854, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.